These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37941919)
1. Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphoma. Su N; Fang Y; Chen X; Chen X; Xia Z; Huang H; Xia Y; Liu P; Tian X; Cai Q Blood Sci; 2023 Oct; 5(4):249-257. PubMed ID: 37941919 [TBL] [Abstract][Full Text] [Related]
2. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma. Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694 [TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma. Fan FY; Deng R; Yi H; Sun HP; Zeng Y; He GC; Su Y Int J Oncol; 2017 Jul; 51(1):316-326. PubMed ID: 28534937 [TBL] [Abstract][Full Text] [Related]
7. Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle. Møller LLV; Jaurji M; Kjøbsted R; Joseph GA; Madsen AB; Knudsen JR; Lundsgaard AM; Andersen NR; Schjerling P; Jensen TE; Krauss RS; Richter EA; Sylow L J Physiol; 2020 Dec; 598(23):5351-5377. PubMed ID: 32844438 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase D1 (PKD1) phosphorylation on Ser Chang JK; Ni Y; Han L; Sinnett-Smith J; Jacamo R; Rey O; Young SH; Rozengurt E J Biol Chem; 2017 Jun; 292(23):9523-9539. PubMed ID: 28408623 [TBL] [Abstract][Full Text] [Related]
9. PAK1 overexpression promotes myxofibrosarcoma angiogenesis through STAT5B-mediated Li CF; Chan TC; Fang FM; Yu SC; Huang HY Int J Biol Sci; 2023; 19(12):3920-3936. PubMed ID: 37564209 [TBL] [Abstract][Full Text] [Related]
10. Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer. Park J; Kim JM; Park JK; Huang S; Kwak SY; Ryu KA; Kong G; Park J; Koo BS Head Neck; 2015 Jul; 37(7):953-63. PubMed ID: 24634274 [TBL] [Abstract][Full Text] [Related]
11. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919 [TBL] [Abstract][Full Text] [Related]
12. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21. Wang Y; Gu X; Li W; Zhang Q; Zhang C J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of AIOLOS induces apoptosis and enhances etoposide chemosensitivity in Jurkat leukemia cells. Zhuang Y; Lu Y; Li D; Sun N; Ju X Oncol Rep; 2015 Mar; 33(3):1319-25. PubMed ID: 25524659 [TBL] [Abstract][Full Text] [Related]
14. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia. Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071 [TBL] [Abstract][Full Text] [Related]
16. PAK1 and PAK2 have different roles in HGF-induced morphological responses. Bright MD; Garner AP; Ridley AJ Cell Signal; 2009 Dec; 21(12):1738-47. PubMed ID: 19628037 [TBL] [Abstract][Full Text] [Related]
17. Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp. Weisz Hubsman M; Volinsky N; Manser E; Yablonski D; Aronheim A Biochem J; 2007 Jun; 404(3):487-97. PubMed ID: 17355222 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16. Qian D; Chen K; Deng H; Rao H; Huang H; Liao Y; Sun X; Lu S; Yuan Z; Xie D; Cai Q Clin Cancer Res; 2015 Nov; 21(21):4881-91. PubMed ID: 26100275 [TBL] [Abstract][Full Text] [Related]
19. CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma. Song Y; Song W; Li Z; Song W; Wen Y; Li J; Xia Q; Zhang M Front Oncol; 2020; 10():488. PubMed ID: 32391258 [TBL] [Abstract][Full Text] [Related]
20. The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity. Thullberg M; Gad A; Beeser A; Chernoff J; Strömblad S Oncogene; 2007 Mar; 26(12):1820-8. PubMed ID: 17001318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]